Smithbridge Asset Management Inc Novo Nordisk A S Transaction History

Smithbridge Asset Management Inc

  • $573 Million
  • Q3 2024

A detailed history of Smithbridge Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 89,120 shares of NVO stock, worth $9.59 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
89,120
Previous 92,327 3.47%
Holding current value
$9.59 Million
Previous $13.2 Million 19.48%
% of portfolio
1.85%
Previous 2.76%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$119.07 - $145.42 $381,857 - $466,361
-3,207 Reduced 3.47%
89,120 $10.6 Million
Q2 2024

Jul 19, 2024
SELL
$122.71 - $146.91 $20,369 - $24,387
-166 Reduced 0.18%
92,327 $13.2 Million
Q1 2024

May 03, 2024
SELL
$102.11 - $135.92 $319,400 - $425,157
-3,128 Reduced 3.27%
92,493 $11.9 Million
Q4 2023

Jan 18, 2024
SELL
$87.78 - $105.45 $145,451 - $174,730
-1,657 Reduced 1.7%
95,621 $9.89 Million
Q3 2023

Oct 25, 2023
BUY
$90.94 - $199.54 $4.29 Million - $9.42 Million
47,185 Added 94.19%
97,278 $8.85 Million
Q2 2023

Jul 20, 2023
SELL
$155.98 - $172.65 $562,619 - $622,748
-3,607 Reduced 6.72%
50,093 $8.11 Million
Q2 2023

Jul 18, 2023
BUY
$155.98 - $172.65 $345,807 - $382,765
2,217 Added 4.31%
53,700 $7.27 Million
Q1 2023

Apr 20, 2023
SELL
$132.34 - $159.14 $293,397 - $352,813
-2,217 Reduced 4.13%
51,483 $8.19 Million
Q4 2022

Mar 01, 2023
SELL
$102.55 - $135.33 $38,558 - $50,884
-376 Reduced 0.7%
53,700 $7.27 Million
Q3 2022

Oct 25, 2022
BUY
$95.28 - $116.93 $46,401 - $56,944
487 Added 0.91%
54,076 $5.39 Million
Q2 2022

Aug 03, 2022
SELL
$103.24 - $121.81 $34,172 - $40,319
-331 Reduced 0.61%
53,589 $5.97 Million
Q1 2022

Apr 25, 2022
SELL
$93.1 - $112.54 $28,395 - $34,324
-305 Reduced 0.56%
53,920 $5.99 Million
Q4 2021

Jan 24, 2022
SELL
$95.88 - $117.08 $232,413 - $283,801
-2,424 Reduced 4.28%
54,225 $6.07 Million
Q3 2021

Oct 04, 2021
SELL
$84.42 - $106.62 $171,119 - $216,118
-2,027 Reduced 3.45%
56,649 $5.44 Million
Q2 2021

Jul 23, 2021
BUY
$67.66 - $84.76 $35,995 - $45,092
532 Added 0.91%
58,676 $4.92 Million
Q1 2021

Apr 06, 2021
BUY
$67.06 - $75.82 $71,754 - $81,127
1,070 Added 1.87%
58,144 $3.92 Million
Q4 2020

Jan 21, 2021
SELL
$63.89 - $73.8 $38,653 - $44,649
-605 Reduced 1.05%
57,074 $3.99 Million
Q3 2020

Oct 29, 2020
SELL
$63.69 - $70.22 $10,827 - $11,937
-170 Reduced 0.29%
57,679 $4.01 Million
Q2 2020

Jul 01, 2020
SELL
$58.54 - $67.94 $298,554 - $346,494
-5,100 Reduced 8.1%
57,849 $3.79 Million
Q1 2020

Apr 13, 2020
SELL
$49.46 - $64.78 $328,661 - $430,463
-6,645 Reduced 9.55%
62,949 $3.79 Million
Q4 2019

Jan 09, 2020
SELL
$49.86 - $58.26 $355,252 - $415,102
-7,125 Reduced 9.29%
69,594 $4.03 Million
Q3 2019

Oct 15, 2019
BUY
$47.54 - $53.43 $37,794 - $42,476
795 Added 1.05%
76,719 $3.97 Million
Q2 2019

Jul 09, 2019
SELL
$46.79 - $52.47 $4,211 - $4,722
-90 Reduced 0.12%
75,924 $3.88 Million
Q1 2019

Apr 03, 2019
BUY
$46.36 - $52.63 $49,837 - $56,577
1,075 Added 1.43%
76,014 $3.98 Million
Q4 2018

Jan 15, 2019
BUY
$41.54 - $47.25 $66,297 - $75,411
1,596 Added 2.18%
74,939 $3.45 Million
Q3 2018

Oct 05, 2018
BUY
$46.76 - $51.24 $24,315 - $26,644
520 Added 0.71%
73,343 $3.46 Million
Q2 2018

Jul 18, 2018
BUY
$44.29 - $50.42 $21,702 - $24,705
490 Added 0.68%
72,823 $3.36 Million
Q1 2018

Apr 09, 2018
SELL
$48.49 - $58.14 $59,836 - $71,744
-1,234 Reduced 1.68%
72,333 $3.56 Million
Q4 2017

Jan 18, 2018
BUY
$47.53 - $53.73 $132,133 - $149,369
2,780 Added 3.93%
73,567 $3.95 Million
Q3 2017

Oct 12, 2017
BUY
$41.15 - $49.22 $2.91 Million - $3.48 Million
70,787
70,787 $3.41 Million

Others Institutions Holding NVO

# of Institutions
1,951
Shares Held
320M
Call Options Held
5.22M
Put Options Held
5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Smithbridge Asset Management Inc Portfolio

Follow Smithbridge Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email